A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients
Open Access
- 20 January 2009
- journal article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 9 (1) , 5
Abstract
The aim of this study was to determine the rate of sustained virological response (SVR) and various factors associated with response rates in chronic hepatitis C infected patients treated with interferon alpha and ribavirin combination therapy.Keywords
This publication has 21 references indexed in Scilit:
- Changes in haemoglobin during interferon alpha‐2b plus ribavirin combination therapy for chronic hepatitis C virus infectionJournal of Viral Hepatitis, 2004
- Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment responseHepatology, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α TherapyScience, 1998
- Factors predictive of a beneficial response to therapy of hepatitis CHepatology, 1997
- Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.Gut, 1993
- Significance of serum hepatitis C virus RNA levels in chronic hepatitis CThe Lancet, 1993
- HCV genotypes in chronic hepatitis C and response to interferonThe Lancet, 1992
- Avoiding false positives with PCRNature, 1989